{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:44:17Z","timestamp":1761101057552},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Infection with cytomegalovirus (CMV) remains a significant cause of morbidity and mortality following allogeneic bone marrow transplantation (allo-BMT). The manifestations of CMV infection can range from neurological and haematological abnormalities to diminished graft survival and, in extreme cases, death. Many clinical studies have shown a direct correlation between cytomegalovirus infection and increased morbidity and mortality post allo-BMT, yet the exact mechanism is not well understood. Although driven primarily by T cell responses, the role of complement activation in acute and chronic graft-versus-host disease (GVHD) has also become more evident in recent years. The present studies were performed to examine the effects of murine cytomegalovirus (MCMV) infection on decay accelerating factor (DAF) and MCMVs role in exacerbating morbidity and mortality post-allo-BMT. Mice infected previously with a sublethal dose of MCMV (1\u2003\u00d7\u2003105 plaque-forming units) have reduced expression of DAF on lung tissues and lymphocytes following allo-BMT. More importantly, mortality rates post-allo-BMT in recipient DAF knock-out mice receiving wild-type bone marrow are increased, similar to wild-type MCMV-infected recipient mice. Similarly, DAF knock-out mice showed greater intracellular interferon (IFN)-\u03b3 production by lung CD8 T cells, and infection with MCMV further exacerbated both intracellular IFN-\u03b3 production by CD8 T cells and mortality rates post-allo-BMT. Together, these data support the hypothesis that MCMV infection augments morbidity and mortality post-allo-BMT by reducing surface DAF expression.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04241.x","type":"journal-article","created":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T11:05:53Z","timestamp":1284462353000},"page":"379-391","source":"Crossref","is-referenced-by-count":8,"title":["Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expression"],"prefix":"10.1093","volume":"162","author":[{"given":"I S","family":"El-Amouri","sequence":"first","affiliation":[{"name":"Center of Excellence in Reproductive Sciences, University of Kentucky, Lexington, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bani-Ahmad","sequence":"additional","affiliation":[{"name":"Center of Excellence in Reproductive Sciences, University of Kentucky, Lexington, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Tang-Feldman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious and Immunologic Diseases, University of California, Davis Medical Center, Sacramento, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Lin","sequence":"additional","affiliation":[{"name":"Case Western Reserve University, Cleveland, OH, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Ko","sequence":"additional","affiliation":[{"name":"Center of Excellence in Reproductive Sciences, University of Kentucky, Lexington, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Pomeroy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Infectious and Immunologic Diseases, University of California, Davis Medical Center, Sacramento, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O R","family":"Oakley","sequence":"additional","affiliation":[{"name":"Center of Excellence in Reproductive Sciences, University of Kentucky, Lexington, KY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"2021122708483655400_b1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bmt.1701069","article-title":"Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Fukuoka Bone Marrow Transplantation Group","volume":"21","author":"Nagafuji","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"2021122708483655400_b2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2169\/internalmedicine1962.29.595","article-title":"Cytomegalovirus pneumonitis occurring after allogeneic bone marrow transplantation: a study of 106 recipients","volume":"29","author":"Nomura","year":"1990","journal-title":"Jpn J Med"},{"key":"2021122708483655400_b3","first-page":"903","article-title":"Fatal pneumococcal infections following allogeneic bone marrow transplant","volume":"14","author":"Rege","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"2021122708483655400_b4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5858\/2005-129-366-PCABMT","article-title":"Pulmonary complications after bone marrow transplantation: an autopsy study from a large transplantation center","volume":"129","author":"Roychowdhury","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"2021122708483655400_b5","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/106002809603001113","article-title":"Cytomegalovirus prophylaxis and treatment following bone marrow transplantation","volume":"30","author":"Tsinontides","year":"1996","journal-title":"Ann Pharmacother"},{"key":"2021122708483655400_b6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jcp.54.2.84","article-title":"Investigation of CMV disease in immunocompromised patients","volume":"54","author":"Emery","year":"2001","journal-title":"J Clin Pathol"},{"key":"2021122708483655400_b7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bmt.1702140","article-title":"Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases","volume":"25","author":"Bleggi-Torres","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"2021122708483655400_b8","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.humimm.2004.02.013","article-title":"Cytomegalovirus infection after bone marrow transplantation in children","volume":"65","author":"Castagnola","year":"2004","journal-title":"Hum Immunol"},{"key":"2021122708483655400_b9","first-page":"675","article-title":"Autopsy-identified infections among bone marrow transplant recipients: a clinico-pathologic study of 56 patients. Bone Marrow Transplantation Team","volume":"16","author":"Chandrasekar","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"2021122708483655400_b10","first-page":"347","article-title":"Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies","volume":"18","author":"Couriel","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"2021122708483655400_b11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1113","article-title":"The complement system in regulation of adaptive immunity","volume":"5","author":"Carroll","year":"2004","journal-title":"Nat Immunol"},{"key":"2021122708483655400_b12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0952-7915(98)80028-9","article-title":"Linkages of innate and adaptive immunity","volume":"10","author":"Carroll","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"2021122708483655400_b13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2567.2000.00009.x","article-title":"The role of complement in the acquired immune response","volume":"100","author":"Nielsen","year":"2000","journal-title":"Immunology"},{"key":"2021122708483655400_b14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1189\/jlb.72.2.249","article-title":"Complement's participation in acquired immunity","volume":"72","author":"Nielsen","year":"2002","journal-title":"J Leukoc Biol"},{"key":"2021122708483655400_b15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0167-5699(00)01754-0","article-title":"Natural antibodies and complement link innate and acquired immunity","volume":"21","author":"Ochsenbein","year":"2000","journal-title":"Immunol Today"},{"key":"2021122708483655400_b16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Kim","year":"2006","journal-title":"Clin Immunol"},{"key":"2021122708483655400_b17","first-page":"439","article-title":"Murine membrane inhibitor of complement which accelerates decay of human C3 convertase","volume":"68","author":"Kameyoshi","year":"1989","journal-title":"Immunology"},{"key":"2021122708483655400_b18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.iy.07.040189.000343","article-title":"Decay-accelerating factor: biochemistry, molecular biology, and function","volume":"7","author":"Lublin","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"2021122708483655400_b19","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1084\/jem.165.3.848","article-title":"Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids","volume":"165","author":"Medof","year":"1987","journal-title":"J Exp Med"},{"key":"2021122708483655400_b20","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1084\/jem.166.5.1221","article-title":"The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb","volume":"166","author":"Fujita","year":"1987","journal-title":"J Exp Med"},{"key":"2021122708483655400_b21","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1073\/pnas.80.16.5066","article-title":"Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor","volume":"80","author":"Nicholson-Weller","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122708483655400_b22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2141.1988.tb07606.x","article-title":"Decay-accelerating factor (DAF) on the blood cell membranes in patients with paroxysmal nocturnal haemoglobinuria (PNH): measurement by enzyme-linked immunosorbent assay (ELISA)","volume":"69","author":"Ninomiya","year":"1988","journal-title":"Br J Haematol"},{"key":"2021122708483655400_b23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2141.1989.tb00234.x","article-title":"Prolongation of red-cell life-span by incorporation of decay-accelerating factor (DAF) into red cells of paroxysmal nocturnal haemoglobinuria (PNH)","volume":"73","author":"Ninomiya","year":"1989","journal-title":"Br J Haematol"},{"key":"2021122708483655400_b24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.20041967","article-title":"Decay-accelerating factor modulates induction of T cell immunity","volume":"201","author":"Heeger","year":"2005","journal-title":"J Exp Med"},{"key":"2021122708483655400_b25","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.4049\/jimmunol.179.9.5793","article-title":"Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production","volume":"179","author":"Lalli","year":"2007","journal-title":"J Immunol"},{"key":"2021122708483655400_b26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.20040863","article-title":"The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo","volume":"201","author":"Liu","year":"2005","journal-title":"J Exp Med"},{"key":"2021122708483655400_b27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.it.2005.12.008","article-title":"Holding T cells in check\u2003\u2013\u2003a new role for complement regulators?","volume":"27","author":"Longhi","year":"2006","journal-title":"Trends Immunol"},{"key":"2021122708483655400_b28","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.184.3.1185","article-title":"The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)","volume":"184","author":"Hamann","year":"1996","journal-title":"J Exp Med"},{"key":"2021122708483655400_b29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0165-5728(02)00306-5","article-title":"Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis","volume":"132","author":"Visser","year":"2002","journal-title":"J Neuroimmunol"},{"key":"2021122708483655400_b30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1677\/joe.1.06218","article-title":"Decay-accelerating factor in the periovulatory rat ovary","volume":"186","author":"Gieske","year":"2005","journal-title":"J Endocrinol"},{"key":"2021122708483655400_b31","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.lab.2003.11.004","article-title":"Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis","volume":"143","author":"Makidono","year":"2004","journal-title":"J Lab Clin Med"},{"key":"2021122708483655400_b32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.healun.2008.01.008","article-title":"Decay-accelerating factor expression may provide immunoprotection against antibody-mediated cardiac allograft rejection","volume":"27","author":"Gonzalez-Stawinski","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"2021122708483655400_b33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/01.tp.0000188176.18666.68","article-title":"Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-alphaGal natural antibodies","volume":"81","author":"Shimizu","year":"2006","journal-title":"Transplantation"},{"key":"2021122708483655400_b34","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.TP.0000133309.82387.8C","article-title":"Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation","volume":"78","author":"Manez","year":"2004","journal-title":"Transplantation"},{"key":"2021122708483655400_b35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1365-2567.2001.01287.x","article-title":"Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies","volume":"104","author":"Lin","year":"2001","journal-title":"Immunology"},{"key":"2021122708483655400_b36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01315153","article-title":"Neutralization of different strains of murine cytomegalovirus (MCMV)-effect of in vitro passage","volume":"69","author":"Chong","year":"1981","journal-title":"Arch Virol"},{"key":"2021122708483655400_b37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-2143(98)90007-5","article-title":"Role of interferon-gamma in murine cytomegalovirus infection","volume":"132","author":"Pomeroy","year":"1998","journal-title":"J Lab Clin Med"},{"key":"2021122708483655400_b38","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/jcm.16.3.542-544.1982","article-title":"Methylcellulose media for plaque assay of murine leukemia virus","volume":"16","author":"Watanabe","year":"1982","journal-title":"J Clin Microbiol"},{"key":"2021122708483655400_b39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jviromet.2005.07.013","article-title":"Use of quantitative real-time PCR (qRT-PCR) to measure cytokine transcription and viral load in murine cytomegalovirus infection","volume":"131","author":"Tang-Feldman","year":"2006","journal-title":"J Virol Methods"},{"key":"2021122708483655400_b40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00043764-200011000-00015","article-title":"Prevalence of cytomegalovirus infection among health care workers in pediatric and immunosuppressed adult units","volume":"42","author":"Sobaszek","year":"2000","journal-title":"J Occup Environ Med"},{"key":"2021122708483655400_b41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virusres.2005.05.008","article-title":"A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression","volume":"114","author":"Qureshi","year":"2005","journal-title":"Virus Res"},{"key":"2021122708483655400_b42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1593\/neo.05679","article-title":"Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo","volume":"8","author":"Loberg","year":"2006","journal-title":"Neoplasia"},{"key":"2021122708483655400_b43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jviromet.2007.01.006","article-title":"A flow cytometry-based method for detecting antibody responses to murine cytomegalovirus infection","volume":"142","author":"Bickerstaff","year":"2007","journal-title":"J Virol Methods"},{"key":"2021122708483655400_b44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.immuni.2004.06.007","article-title":"TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function","volume":"21","author":"Krug","year":"2004","journal-title":"Immunity"},{"key":"2021122708483655400_b45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molimm.2004.03.019","article-title":"The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma","volume":"41","author":"Hawlisch","year":"2004","journal-title":"Mol Immunol"},{"key":"2021122708483655400_b46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2174\/187152809788681038","article-title":"The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses","volume":"8","author":"Peng","year":"2009","journal-title":"Inflamm Allergy Drug Targets"},{"key":"2021122708483655400_b47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000467889","article-title":"Biochemistry and biology of anaphylatoxins","volume":"3","author":"Hugli","year":"1986","journal-title":"Complement"},{"key":"2021122708483655400_b48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.bmt.1702538","article-title":"Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation","volume":"26","author":"De Medeiros","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"2021122708483655400_b49","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1086\/318724","article-title":"Prevention of cytomegalovirus disease in recipients of solid-organ transplants","volume":"32","author":"Paya","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2021122708483655400_b50","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/00007890-199811270-00012","article-title":"Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients","volume":"66","author":"Ljungman","year":"1998","journal-title":"Transplantation"},{"key":"2021122708483655400_b51","doi-asserted-by":"crossref","first-page":"A148","DOI":"10.1007\/BF01715370","article-title":"Risk factors for viral reactivation following bone marrow transplantation","volume":"64","author":"Pillay","year":"1992","journal-title":"Ann Hematol"},{"issue":"4","key":"2021122708483655400_b52","first-page":"S19","article-title":"The lung as a critical organ in marrow transplantation","volume":"14","author":"Quabeck","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"2021122708483655400_b53","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.4049\/jimmunol.161.4.1913","article-title":"Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages","volume":"161","author":"Clark","year":"1998","journal-title":"J Immunol"},{"key":"2021122708483655400_b54","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.4049\/jimmunol.158.12.5805","article-title":"Intermediate TCR cells in mouse lung: their effector function to induce pneumonitis in mice with autoimmune-like graft-versus-host disease","volume":"158","author":"Watanabe","year":"1997","journal-title":"J Immunol"},{"key":"2021122708483655400_b55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bmt.1705484","article-title":"Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease","volume":"38","author":"Huisman","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"2021122708483655400_b56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0090-1229(86)90025-5","article-title":"Usual interstitial pneumonitis is a T-cell alveolitis","volume":"40","author":"Kradin","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"2021122708483655400_b57","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1172\/JCI4174","article-title":"Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease","volume":"102","author":"Enelow","year":"1998","journal-title":"J Clin Invest"},{"key":"2021122708483655400_b58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1183\/09031936.93.05070791","article-title":"Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage","volume":"5","author":"Costabel","year":"1992","journal-title":"Eur Respir J"},{"key":"2021122708483655400_b59","doi-asserted-by":"crossref","first-page":"L1042","DOI":"10.1152\/ajplung.00155.2004","article-title":"Interferon-gamma: a key contributor to hyperoxia-induced lung injury in mice","volume":"287","author":"Yamada","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2021122708483655400_b60","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm933","article-title":"Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses","volume":"9","author":"Stager","year":"2003","journal-title":"Nat Med"},{"key":"2021122708483655400_b61","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.170.2.788","article-title":"Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection","volume":"170","author":"Suresh","year":"2003","journal-title":"J Immunol"},{"key":"2021122708483655400_b62","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/eji.1830260719","article-title":"Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells","volume":"26","author":"Spiller","year":"1996","journal-title":"Eur J Immunol"},{"key":"2021122708483655400_b63","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.4049\/jimmunol.152.4.1727","article-title":"Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes","volume":"152","author":"Thornton","year":"1994","journal-title":"J Immunol"},{"key":"2021122708483655400_b64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.167.1.163","article-title":"The role of the CD19\/CD21 complex in B cell processing and presentation of complement-tagged antigens","volume":"167","author":"Cherukuri","year":"2001","journal-title":"J Immunol"},{"key":"2021122708483655400_b65","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.healun.2008.03.018","article-title":"C3d and C4d deposition early after lung transplantation","volume":"27","author":"Westall","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"2021122708483655400_b66","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.humimm.2005.11.001","article-title":"C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction","volume":"67","author":"Magro","year":"2006","journal-title":"Hum Immunol"},{"key":"2021122708483655400_b67","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm0402-373","article-title":"Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection","volume":"8","author":"Kopf","year":"2002","journal-title":"Nat Med"},{"key":"2021122708483655400_b68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"key":"2021122708483655400_b69","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2008-04-151068","article-title":"Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis","volume":"112","author":"Lalli","year":"2008","journal-title":"Blood"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04241.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/162\/2\/379\/41924245\/j.1365-2249.2010.04241.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/162\/2\/379\/41924245\/j.1365-2249.2010.04241.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T09:11:48Z","timestamp":1685783508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/162\/2\/379\/6438609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,9,14]]},"published-print":{"date-parts":[[2010,10,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04241.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,11]]},"published":{"date-parts":[[2010,9,14]]}}}